A multi-stage healthcare and life sciences investment platform is focused on addressing areas of significant unmet medical need by backing companies across all stages of development. The firm applies a data science–driven investment approach, prioritizing businesses that leverage biology and large-scale data to transform healthcare delivery and outcomes.
The firm is broadly interested across the healthcare landscape, including medical technology, therapeutics, diagnostics, laboratory equipment, healthcare IT, and R&D services. Within medical technology, the firm seeks companies with at least an alpha-stage prototype supported by initial efficacy data. Within therapeutics, the firm primarily targets assets in Phase II clinical development and will consider Phase I programs only when supported by clear efficacy data.
From a company and management team perspective, the firm looks for a strong and capable management team to be in place. The firm is open to investing in both privately held and publicly traded companies. For private investments, the firm generally seeks to take a board seat.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment